Details of the Drug
General Information of Drug (ID: DMHK25N)
Drug Name |
2-Mercaptomethyl-pentanedioic acid
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
2-Mercaptomethylglutaric acid; 2-Mercaptomethyl-pentanedioic acid; CHEMBL60941; 106146-19-4; Pentanedioic acid,2-(mercaptomethyl)-; 2-Mmga; 2-(sulfanylmethyl)pentanedioic acid; ACMC-1BUG7; AC1L2VT3; 2-mer-captomethylglutaric acid; SCHEMBL1278279; CTK4A4424; Glutaric acid, 2-mercaptomethyl-; LDFDXRPEWZHIML-UHFFFAOYSA-N; NSC613827; BDBM50127614
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 178.21 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | -0.1 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 5 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 3 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 5 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||